Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXPRESSMOM2 in Pregnant Women at High Risk of Preterm Birth. Aspects of Antenatal Breastmilk Expression and Safety From Gestational Week 28-34 and Potential Nutritional Benefits for the Newborn Infant.

NCT07191366 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT07191366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXPRESSMOM2 in Pregnant Women at High Risk of Preterm Birth. Aspects of Antenatal Breastmilk Expression and Safety From Gestational Week 28-34 and Potential Nutritional Benefits for the Newborn Infant.
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
July 31, 2029
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pprom, preeclampsia, preterm birth, previous preterm birth